IDH1 and glioblastoma: CAT for QQ-based OEF mapping, along with DCE perfusion MRI, enables superior predictability of the molecular characteristics including IDH mutation, MGMT promoter methylation status and RTK subgroup, and fair performance in differentiation of GBM vs. LGG.